Emedgene, a Palo Alto, CA-based artificial intelligence (AI) driven genomics interpretation platform, today announced it has raised $6 million in funding led by health-focused OliveTree Ventures. The company plans to utilize the latest round of funding to expand sales operations in the US. Emedgene's Genomics Intelligence Platform OverviewThis rise in genomics-based medicine is putting tremendous pressure on geneticists globally - who must analyze and interpret each test. It is a costly,
Read More
10 Major Themes Driving The Future of Blockchain in Healthcare
Partners in Digital Health, communications company publishing the peer review journals Blockchain in Healthcare Today (BHTY) has announced their first annual BHTY Top 10 Blockchain Predictions for Healthcare 2019. With over 20,000 downloads, 18 citations, and readership in over 65 countries worldwide, Blockchain Healthcare Today (BHTY) is the preeminent open-access international peer-review journal for strategic thought leaders, new-era practitioners, and future society stakeholders engaged in
Read More
NextFlex, Profusa Unveils Injectable Biosensor for Continuous Oxygen Monitoring in Tissue
Today at FLEX 2019, integrated biosensor makers Profusa and NextFlex unveiled a skin-worn reader prototype with an injected hydrogel biosensor for continuous oxygen monitoring in tissue. The Lumee™ Oxygen Platform is intended for use in patients with potential acute and/or chronic changes in tissue oxygen levels who may benefit from continuous monitoring. Lumee Oxygen Hydrogel Biosensor The Lumee Oxygen Hydrogel biosensor, a tiny flexible fiber (3 mm to 5 mm long and approximately 500 microns in
Read More
Glooko Launches Integration with Novo Nordisk Insulin Pen
Today, Glooko announced the launch of their integration with the Novo Nordisk connected insulin pen on our diasend® platform and the release of their Annual Diabetes Report. With diasend, doctors were able to see and advise patients based on recorded insulin dose data from connected Novo Nordisk pens without having to invest additional time. Now, to raise the bar for patient convenience even further, Glooko is launching the ability to also upload pen data remotely – straight from any near field
Read More
Teckro Lands $25M to Make Clinical Trials Data Accessible to Research Staff
Teckro, an NYC-based technology platform that makes the conduct of clinical trials simple, more transparent and more inclusive for doctors, research nurses and patients announced it has raised $25 million in funding. The Series C funding round was led by Northpond Ventures with participation from Founders Fund, Sands Capital Ventures, Bill Maris’ Section 32 venture fund, and Borealis Ventures. Teckro’s total funding now stands at $43 million.Making Your Clinical Trial Information Instantly
Read More
FDA Authorizes Interoperable Tandem Insulin Pump for Personalized Diabetes Management
The U.S. Food and Drug Administration (FDA) has permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes. This new type of insulin pump, Referred to as an alternate controller enabled (ACE) infusion pump, or ACE insulin pump, is the first interoperable insulin pump, meaning it can be used with different components that make up diabetes therapy systems,
Read More
HIMSS19 Day 3 Announcements & Summary
Johnson & Johnson to Acquire Auris Health for $3.4B to Expand Digital Surgery PortfolioJohnson & Johnson, today announced it has entered into a definitive agreement to acquire Auris Health, a developer of robotic technologies for $3.4 billion in cash. Auris Health is a privately held developer of robotic technologies, initially focused on lung cancer, with an FDA-cleared Monarch platform currently used in bronchoscopic diagnostic and therapeutic procedures. This acquisition will
Read More
IBM Watson Health Invests $50M in AI to Tackle Public Health Issues
IBM Watson Health announced plans to make a 10-year, $50 million investment in joint research collaborations to advance the use of artificial intelligence (AI) to tackle public health issues. Brigham and Women’s Hospital – the teaching hospital of Harvard Medical School – and Vanderbilt University Medical Center have been selected as joint research partners. AI Research Focus AreasThe initial areas of study are expected to include the use of AI to improve the utility of electronic health records
Read More
Johnson & Johnson to Acquire Auris Health for $3.4B to Expand Digital Surgery Portfolio
Johnson & Johnson, today announced it has entered into a definitive agreement to acquire Auris Health, a developer of robotic technologies for $3.4 billion in cash. Auris Health is a privately held developer of robotic technologies, initially focused on lung cancer, with an FDA-cleared Monarch platform currently used in bronchoscopic diagnostic and therapeutic procedures. This acquisition will accelerate Johnson & Johnson’s entry into robotics and strengthens its digital surgery
Read More
Propeller Health Partners with Orion’s Easyhaler Line of Inhalers for Asthma
Orion and Propeller Health have announced a partnership to connect Orion's Easyhaler line of inhalers for asthma and COPD to Propeller's digital medicine platform. Propeller and Orion will partner to develop a custom sensor for Easyhaler, which will attach to the inhaler and pair to Propeller’s mobile app to track medication use and provide personal feedback. Development begins in 2019, with clinical trials and commercial roll-out to follow. This partnership expands Propeller’s presence in
Read More